WINMED Stock Overview
Engages in the distribution of medical and diagnostic equipment in Thailand. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Winnergy Medical Public Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ฿1.97 |
52 Week High | ฿3.18 |
52 Week Low | ฿1.50 |
Beta | 0.12 |
11 Month Change | -1.50% |
3 Month Change | 14.53% |
1 Year Change | -34.33% |
33 Year Change | -66.03% |
5 Year Change | n/a |
Change since IPO | -66.61% |
Recent News & Updates
Recent updates
Shareholder Returns
WINMED | TH Healthcare | TH Market | |
---|---|---|---|
7D | -4.4% | -1.2% | -0.3% |
1Y | -34.3% | -9.6% | 2.0% |
Return vs Industry: WINMED underperformed the TH Healthcare industry which returned -9.6% over the past year.
Return vs Market: WINMED underperformed the TH Market which returned 2% over the past year.
Price Volatility
WINMED volatility | |
---|---|
WINMED Average Weekly Movement | 4.7% |
Healthcare Industry Average Movement | 4.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in TH Market | 10.3% |
10% least volatile stocks in TH Market | 2.5% |
Stable Share Price: WINMED has not had significant price volatility in the past 3 months compared to the TH market.
Volatility Over Time: WINMED's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | n/a | Nanthiya Darakananda | www.winnergymedical.co.th |
Winnergy Medical Public Company Limited engages in the distribution of medical and diagnostic equipment in Thailand. The company sells women healthcare products, which includes down’s syndrome and genetic screening test, pregnancy monitoring, and cervical dilators; equipment for testing blood quality to donate blood; blood infection testing products; and stem cell and contamination analysis products. It also sells mosquito trappers for outdoor and indoor use; and offers COVID-19 diagnostic lab services.
Winnergy Medical Public Company Limited Fundamentals Summary
WINMED fundamental statistics | |
---|---|
Market cap | ฿788.00m |
Earnings (TTM) | ฿27.73m |
Revenue (TTM) | ฿618.97m |
28.4x
P/E Ratio1.3x
P/S RatioIs WINMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WINMED income statement (TTM) | |
---|---|
Revenue | ฿618.97m |
Cost of Revenue | ฿374.69m |
Gross Profit | ฿244.28m |
Other Expenses | ฿216.55m |
Earnings | ฿27.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.069 |
Gross Margin | 39.47% |
Net Profit Margin | 4.48% |
Debt/Equity Ratio | 17.4% |
How did WINMED perform over the long term?
See historical performance and comparison